The immediate pain relief of low-level laser therapy for burning mouth syndrome: a retrospective study of 94 cases
Wenxin Mu,
No information about this author
Shanshan Li,
No information about this author
Lu Qian
No information about this author
et al.
Frontiers in Oral Health,
Journal Year:
2024,
Volume and Issue:
5
Published: Dec. 18, 2024
Burning
mouth
syndrome
(BMS)
is
a
chronic
orofacial
pain
disorder
that
seriously
affects
quality
of
life
patients.
In
recent
years,
Low-level
laser
therapy
(LLLT)
has
been
regarded
as
an
important
innovation
in
management,
but
there
insufficient
evidence
its
effectiveness
patients
with
painful
BMS.
This
study
aimed
to
evaluate
the
efficacy
LLLT
for
immediate
relief
due
Language: Английский
Evaluating the Impact of Different Treatments on the Quality of Life in Patients With Burning Mouth Syndrome: A Scoping Review
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 29, 2024
The
profound
impact
of
burning
mouth
syndrome
(BMS)
on
patients'
quality
life
(QoL)
highlights
the
critical
need
to
identify
effective
treatments
for
this
condition.
This
study
aims
evaluate
and
compare
health-related
(HRQoL)
oral
(OHRQoL)
among
individuals
diagnosed
with
BMS,
focusing
different
treatment
modalities.
For
that
purpose,
a
scoping
review
was
designed
following
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
(PRISMA)
reporting
guidelines
registration
International
Prospective
Register
(PROSPERO).
An
electronic
search
then
conducted
in
March
2024,
encompassing
databases:
PubMed,
Embase,
Cochrane,
Web
Science,
Trip
Database.
Publications
were
deemed
eligible
if
they
assessed
BMS
QoL.
Out
initial
5400,
only
13
studies
considered
suitable
be
included
review.
instrument
used
HRQoL
36-Item
Short
Form
Survey
(SF-36).
OHRQoL,
preferred
tools
Oral
Health
Impact
Profile
(OHIP)
Geriatric
Assessment
Index
(GOHAI).
Literature
reported
improvements
across
majority
analyzed
However,
low-level
laser
therapy
(LLLT)
n-acetylcysteine
(NAC)
plus
clonazepam
most
improving
OHRQoL.
several
promising
options
both
OHRQoL
BMS.
Nevertheless,
variability
underscores
further
research
establish
consistently
condition,
reflecting
consistent
trial
designs
accurately
assess
true
disease.
Language: Английский
Health-Related Quality of Life with Iatrogenic Inferior Alveolar Nerve Injuries Treated with Photobiomodulation: A Comparative Study
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(23), P. 7237 - 7237
Published: Nov. 28, 2024
Background/Objectives:
Photobiomodulation
therapy
(PBM)
creates
a
biostimulatory
or
modulatory
effect,
promoting
tissue
regeneration
and
improving
patients’
health-related
quality
of
life
(HRQoL).
PBM
has
shown
promise
as
an
effective
treatment
management
strategy
for
peripheral
nerve
injuries,
including
inferior
alveolar
(IAN)
damage.
This
study
aims
to
assess
the
impact
on
HRQoL
in
patients
with
iatrogenic
IAN
injuries.
Methods:
A
prospective
was
implemented
investigate
research
question.
treatments
were
administered
weekly,
patient
discharge
contingent
upon
either
complete
recovery
stabilization
associated
signs
symptoms.
assessed
using
EQ-5D-5L
questionnaire
at
initial
final
appointments.
Results:
The
included
71
participants,
divided
into
3
groups
based
etiology:
third
molar
surgery,
mandibular
orthognathic
dental
implant
surgery.
results
showed
widespread
reduction
symptoms
along
statistically
significant
improvement
(p
<
0.001)
across
four
five
dimensions
questionnaire,
well
perceived
health
levels
both
Groups
I
II.
Group
III
also
demonstrated
notable
improvement;
however,
due
small
sample
size,
statistical
analysis
not
conducted
this
group.
Conclusions:
comparable
ability
enhance
alleviate
injuries
within
different
etiologies.
These
findings
underscore
effectiveness
protocol
used
highlight
potential
avenues
expanding
field.
Language: Английский